Sotagliflozin, suPAR, and Cardiovascular Outcomes in Patients With Diabetes and Heart Failure: A SOLOIST-WHF Ancillary Study.
- DOI
- 10.1016/j.cardfail.2026.01.018
- Published
- 2026 Aug
- Container
- Journal of cardiac failure
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.cardfail.2026.01.018,
title = {Sotagliflozin, suPAR, and Cardiovascular Outcomes in Patients With Diabetes and Heart Failure: A SOLOIST-WHF Ancillary Study.},
author = {Ismail A and Erne G and Vasbinder A and Hutten CG and Ghazzal BZ and Pizzo I and Diaz KM and Catalan TC and Farhat T and Knott B and Kunkle P and Szarek M and Davies MJ and Steg PG and Pitt B and Bhatt DL and Hayek SS},
year = {2026},
journal = {Journal of cardiac failure},
doi = {10.1016/j.cardfail.2026.01.018},
url = {https://doi.org/10.1016/j.cardfail.2026.01.018}
}RIS
TY - JOUR TI - Sotagliflozin, suPAR, and Cardiovascular Outcomes in Patients With Diabetes and Heart Failure: A SOLOIST-WHF Ancillary Study. AU - Ismail A AU - Erne G AU - Vasbinder A AU - Hutten CG AU - Ghazzal BZ AU - Pizzo I AU - Diaz KM AU - Catalan TC AU - Farhat T AU - Knott B AU - Kunkle P AU - Szarek M AU - Davies MJ AU - Steg PG AU - Pitt B AU - Bhatt DL AU - Hayek SS PY - 2026 JO - Journal of cardiac failure DO - 10.1016/j.cardfail.2026.01.018 UR - https://doi.org/10.1016/j.cardfail.2026.01.018 ER -
APA
A, I., G, E., A, V., CG, H., BZ, G., I, P., KM, D., TC, C., T, F., B, K., P, K., M, S., MJ, D., PG, S., B, P., DL, B., & SS, H. (2026). Sotagliflozin, suPAR, and Cardiovascular Outcomes in Patients With Diabetes and Heart Failure: A SOLOIST-WHF Ancillary Study.. Journal of cardiac failure. https://doi.org/10.1016/j.cardfail.2026.01.018
Source records
- pubmed · retrieved 2026-09-25T09:10:46.354Z